Actively Recruiting
Metabolic Phenotypes in Melanoma
Led by Peter MacCallum Cancer Centre, Australia · Updated on 2023-07-06
240
Participants Needed
1
Research Sites
222 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a single centre, correlative, longitudinal, biomarker study that aims to describe the metabolic features of human melanoma using mass spectrometry.
CONDITIONS
Official Title
Metabolic Phenotypes in Melanoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient has provided written informed consent
- Male or female aged 18 years or older at written informed consent
- Presence of a known melanoma lesion requiring surgical excision or biopsy
- Patient is willing and able to comply with the protocol for the duration of the study including undergoing biopsies and receiving a stable isotope infusion (where applicable)
You will not qualify if you...
- Diagnosis of diabetes mellitus
- Pregnancy or breastfeeding
- Inability to comply with study procedures and follow-up as determined by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peter Mac Callum Cancer Centre
Melbourne, Victoria, Australia, 3002
Actively Recruiting
Research Team
A
Aparna Rao
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here